Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication used for the treatment of Zaire ebolavirus (Ebolavirus) infection. The...
25 KB (2,359 words) - 05:28, 29 December 2024
Regeneron product atoltivimab/maftivimab/odesivimab, favipiravir, and ansuvimab) were also considered for use, but they were at earlier stages of development...
24 KB (2,673 words) - 16:46, 2 November 2024
anrukinzumab (USAN, INN) Ansaid Ansolysen ansoxetine (INN) Anspor ansuvimab (USAN, INN) ansuvimab-zykl Antabuse antafenite (INN) Antagon Antagonate antazoline...
8 KB (426 words) - 00:35, 7 March 2025
of 2019[update], two treatments (atoltivimab/maftivimab/odesivimab and ansuvimab) are associated with improved outcomes. Supportive efforts also improve...
194 KB (18,605 words) - 18:59, 6 May 2025
Palivizumab J06BD02 Motavizumab J06BD03 Tixagevimab and cilgavimab J06BD04 Ansuvimab J06BD05 Sotrovimab J06BD06 Regdanvimab J06BD07 Casirivimab and imdevimab...
2 KB (263 words) - 04:26, 7 March 2025
Technology, and Environment Service to America Medal for the development of ansuvimab, an FDA-approved monoclonal antibody for the treatment of Ebola virus...
7 KB (590 words) - 07:55, 28 March 2025
Nifurtimox Complementary: Melarsoprolα Benznidazole Nifurtimox Ivermectin Ansuvimab Atoltivimab/maftivimab/odesivimab (atoltivimab + maftivimab + odesivimab)...
67 KB (4,835 words) - 23:03, 3 May 2025
developed a number of other advanced medications such as monoclonal antibody Ansuvimab against the Ebola virus. Crow, David (30 June 2020). "Hedge fund manager...
6 KB (547 words) - 14:35, 30 October 2023
treatment known as atoltivimab/maftivimab/odesivimab and experimental ansuvimab were found to be 90% effective. In October 2020, the U.S. Food and Drug...
34 KB (3,514 words) - 01:36, 5 February 2025
significantly less effective than monoclonal antibody treatments such as ansuvimab and atoltivimab/maftivimab/odesivimab. The trials, however, established...
112 KB (9,654 words) - 07:12, 14 April 2025
tumor resection in non-small cell lung cancer with EGFR exon 19 deletions or exon 21 L858R mutations Ansuvimab Ridgeback Biotherapeutics Ebola Zaire...
45 KB (240 words) - 04:36, 21 January 2025
A Favipiravir FGI-106 GS-441524 JK-05 Lopinavir/ritonavir Lamivudine Ansuvimab MK-608 Molnupiravir Nelfinavir Oseltamivir Nirmatrelvir/ritonavir Peramivir...
7 KB (561 words) - 20:05, 16 December 2023
Anifrolumab Saphnelo mab human IFN-α/β receptor Y systemic lupus erythematosus Ansuvimab Ebanga mab human Ebola virus glycoprotein Y treatment of Zaire ebolavirus...
141 KB (4,321 words) - 00:07, 11 May 2025
Remdesivir, ZMapp, atoltivimab/maftivimab/odesivimab, ansuvimab and favipiravir. The drug ansuvimab (which is a monoclonal antibody) was deployed for the...
232 KB (18,700 words) - 20:09, 8 April 2025
MPE8 that neutralizes four different paramyxoviruses () and mab114 (Ansuvimab) that has been approved for treatment of Ebola infected patients (). The...
16 KB (1,709 words) - 10:43, 19 December 2024